Atrys Health Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 1,985

Employees

  • Stock Symbol
  • ATRY

Stock Symbol

  • Investments
  • 21

  • Share Price
  • $2.69
  • (As of Friday Closing)

Atrys Health General Information

Description

Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.

Contact Information

Formerly Known As
Althia, eDiagnostic
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Calle Velázquez 157, 4ºA
  • 28002 Madrid
  • Spain
+34 917
Primary Industry
Other Healthcare Services
Stock Exchange
MAD
Vertical(s)
Corporate Office
  • Calle Velázquez 157, 4ºA
  • 28002 Madrid
  • Spain
+34 917

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atrys Health Stock Performance

As of 20-Nov-2026, Atrys Health’s stock price is $2.69. Its current market cap is $204M with 75.9M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.69 $2.80 $2.59 - $3.75 $204M 75.9M 39.8K -$1.50

Atrys Health Financials Summary

As of 30-Jun-2026, Atrys Health has a trailing 12-month revenue of $172M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 499,203 539,245 513,651 571,790
Revenue 172,271 159,057 140,648 218,113
EBITDA (16,048) (11,914) 17,876 30,728
Net Income (113,611) (113,135) (34,383) (49,332)
Total Assets 360,373 580,310 607,896 695,298
Total Debt 135,227 302,894 265,760 280,772
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Atrys Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Atrys Health‘s full profile, request access.

Request a free trial

Atrys Health Patents

Atrys Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2634254-T3 Methods for prognosis of diffuse large b lymphocyte lymphoma Active 12-Sep-2011
EP-2568290-A1 Methods for prognosis of diffuse large b-cell lymphoma Active 12-Sep-2011
EP-2568290-B1 Methods for prognosis of diffuse large b-cell lymphoma Active 12-Sep-2011 G01N33/57505

Atrys Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atrys Health Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Atrys Health‘s full profile, request access.

Request a free trial

Atrys Health Investments & Acquisitions (21)

Atrys Health’s most recent deal was a Merger/Acquisition with Chaxa Radiology. The deal was made on 14-Jun-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Chaxa Radiology 14-Jun-2023 Merger/Acquisition Other Business Products and Services
Grupo SOHIN(Cuidarte clinics) 09-Jan-2023 Corporate Asset Purchase Buildings and Property
Initia Oncologia 28-Dec-2022 Merger/Acquisition Clinics/Outpatient Services
Chilerad 27-Dec-2022 Merger/Acquisition Diagnostic Equipment
Bienzobas 13-Jun-2022 Merger/Acquisition Clinics/Outpatient Services
You’re viewing 5 of 21 investments and acquisitions. Get the full list »

Atrys Health ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Services

Subindustry

Rank

Percentile

To view Atrys Health’s complete esg history, request access »

Atrys Health Exits (1)

Atrys Health’s most recent exit was on 21-Apr-2021 from Aspy Global Services. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Aspy Global Services 21-Apr-2021 Completed
To view Atrys Health’s complete exits history, request access »

Atrys Health Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
Genetyca-ICM Porto, Portugal 2018
SIMM Molecular Barcelona, Spain 2017
Bienzobas Almeria, Spain 2000
IMOR Institute Barcelona, Spain 1999
Initia Oncologia Valencia, Spain

Atrys Health FAQs

  • When was Atrys Health founded?

    Atrys Health was founded in 2007.

  • Where is Atrys Health headquartered?

    Atrys Health is headquartered in Madrid, Spain.

  • What is the size of Atrys Health?

    Atrys Health has 1,985 total employees.

  • What industry is Atrys Health in?

    Atrys Health’s primary industry is Other Healthcare Services.

  • Is Atrys Health a private or public company?

    Atrys Health is a Public company.

  • What is Atrys Health’s stock symbol?

    The ticker symbol for Atrys Health is ATRY.

  • What is the current stock price of Atrys Health?

    As of 20-Nov-2026 the stock price of Atrys Health is $2.69.

  • What is the current market cap of Atrys Health?

    The current market capitalization of Atrys Health is $204M.

  • What is Atrys Health’s current revenue?

    The trailing twelve month revenue for Atrys Health is $172M.

  • What is Atrys Health’s annual earnings per share (EPS)?

    Atrys Health’s EPS for 12 months was -$1.50.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process